135 related articles for article (PubMed ID: 38650801)
1. The Association of the Epidermal Growth Factor Receptor (EGFR) Immunoexpression With Prognostic Parameters in Adenocarcinoma Patients Receiving Neoadjuvant Treatment.
Demir D; Parvizi M; Pehlivanoglu B; Ergin E; Ayhan S; Doganavsargil B
Cureus; 2024 Mar; 16(3):e56763. PubMed ID: 38650801
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
3. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
[TBL] [Abstract][Full Text] [Related]
4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
5. The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Richter I; Dvořák J; Urbanec M; Bluml A; Čermáková E; Bartoš J; Petera J
Contemp Oncol (Pozn); 2015; 19(1):48-53. PubMed ID: 26199571
[TBL] [Abstract][Full Text] [Related]
6. [Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma].
Richter I; Dvořák J; Blüml A; Cermáková E; Bartoš J; Urbanec M; Sitorová V; Ryška A; Sirák I; Buka D; Ferko A; Melichar B; Petera J
Klin Onkol; 2014; 27(5):361-6. PubMed ID: 25312714
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Dvorak J; Sitorova V; Ryska A; Sirak I; Richter I; Hatlova J; Ferko A; Melichar B; Petera J
Strahlenther Onkol; 2012 Sep; 188(9):833-8. PubMed ID: 22847519
[TBL] [Abstract][Full Text] [Related]
8. Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients.
Lim BL; Park IJ; Kim YI; Kim CW; Lee JL; Yoon YS; Lim SB
Ann Surg Treat Res; 2023 Apr; 104(4):205-213. PubMed ID: 37051159
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
11. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
13. Prognostic significance of nodal disease following preoperative radiation for rectal adenocarcinoma.
Rinkus KM; Russell GB; Levine EA
Am Surg; 2002 May; 68(5):482-7. PubMed ID: 12013294
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
17. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.
Giralt J; de las Heras M; Cerezo L; Eraso A; Hermosilla E; Velez D; Lujan J; Espin E; Rosello J; Majó J; Benavente S; Armengol M; de Torres I;
Radiother Oncol; 2005 Feb; 74(2):101-8. PubMed ID: 15816107
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
Azria D; Bibeau F; Barbier N; Zouhair A; Lemanski C; Rouanet P; Ychou M; Senesse P; Ozsahin M; Pèlegrin A; Dubois JB; Thèzenas S
BMC Cancer; 2005 Jun; 5():62. PubMed ID: 15967033
[TBL] [Abstract][Full Text] [Related]
19. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
[No Abstract] [Full Text] [Related]
20. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]